Figure 6
From: Elevated plasma miR-133b and miR-221-3p as biomarkers for early Parkinson’s disease
ROC analysis of plasma miRNAs as PD biomarkers. (a–c) ROC curves of miR-133b (a), miR-221-3p (b), and their combination (c) for discriminating patients with PD (n = 46) from healthy controls (n = 45) in cohort 3. (d) ROC curves of miR-133b for discriminating patients with MSA (n = 21) from healthy controls (n = 45) in cohort 3. (e) ROC curves of miR-4454 for discriminating patients with PD (n = 46) from patients with MSA (n = 21) in cohort 3. PD, Parkinson’s disease; MSA, multiple system atrophy.
